I can appreciate many of your points, however I think that, like most stocks, TAUG will adjust prior to the definitive results; not after. In my opinion, we are reaching the point where many more are willing to speculate those results. This stock has moved twice, solely on speculation and it moved like a wild animal. I think that TAUG is at a pps that is screaming out to the 'speculating' type; not only because it has come down considerably, but because the factors at play in favor of positive results are mounding. Today there are companies with absolutely NONE of the foundation, talent, and business opportunity that TAUG has and constantly dilute shares to stay in business - yet they go up 50% in a day.. Not always speculation - lots of manipulation as well.
Sure, there is plenty of risk to consider and it is foolish not to consider pros and cons. But as we can all agree - in the OTC or with any startup - it comes down to risk/reward. After seeing what TAUG has done on purely 'high hopes', I'm willing to put my coin in the 'what if' pot. ;-)
Thankfully TAUG is a reporting company and we will get all the answers they can give us very soon! Until then, we all have to enjoy the ride for what it is. If you ask me, I'm pleased with this pps area at the moment and those that have waited until recently to purchase aren't complaining either.
Like I said rawman: we might not agree 100% but I can still appreciate your perspective. I'll admit that I share some concerns, but lately TAUG has been showing me what I want to see: effort to sustain value - although pps might not reflect that immediately - they are not sweeping us under the rug like plenty of others - ESPECIALLY biotech companies. TAUG can be loosely compared, but in reality we have technology that is very new and has immense potential for various applications - we are simply focusing on 5-6 (and that is confirmed!) We aren't just looking to swim around in the gutter (pun intended). ;-)